CHINAAMC Hang Seng Biotech ETF (HKG:3069)

HKG:3069 Holdings Information

HKG:3069 is an equity ETF with a total of 10 individual holdings. The top holdings are WuXi Biologics stock at 10.46%, BeOne Medicines AG at 9.35%, Innovent Biologics at 8.48%, Akeso at 8.07%, and CSPC Pharmaceutical Group at 6.59%.

• Total Holdings: 10
• Top 10 Percentage: 67.71%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 1.99B
• PE Ratio: 28.07

Top 25 Holdings

As of Dec 31, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	HKG: 2269	WuXi Biologics (Cayman) Inc.	10.46%	5,634,323
2	HKG: 6160	BeOne Medicines AG	9.35%	883,113
3	HKG: 1801	Innovent Biologics, Inc.	8.48%	1,883,918
4	HKG: 9926	Akeso, Inc.	8.07%	1,210,699
5	HKG: 1093	CSPC Pharmaceutical Group Limited	6.59%	13,253,228
6	HKG: 1177	Sino Biopharmaceutical Limited	6.18%	16,955,563
7	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	5.30%	2,487,008
8	HKG: 1530	3SBio Inc.	4.56%	3,198,070
9	HKG: 2359	WuXi AppTec Co., Ltd.	4.48%	768,691
10	n/a	Citigroup Global Markets Holdings Inc.	4.24%	4,400